Safety of long-acting malaria prevention injection in healthy people
Part of Infections clinical trials.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 50 years old
- You are generally healthy and not currently sick with malaria
- You weigh at least 35 kg (77 lbs) if you are 12-17, or 45 kg (99 lbs) if you are 18-50
- If you can become pregnant, you must use contraception and not be pregnant or breastfeeding
- You have not taken malaria medication or certain antibiotics recently
- You do not have certain heart, liver, or bleeding conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This study tests a new investigational drug (GSK4425689A) for the first time in humans. It is a healthy volunteer study to check the safety, side effects, and how the drug moves through the body. It may help in the future development of treatments for malaria.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.